Urinary hepcidin levels in children with beta-thalassemia major on chelation therapy

Urinary hepcidin levels in children with beta-thalassemia major on chelation therapy

Bibliographic Details
Main Authors:	Kritika Goel, Dheeraj Bahl, Parul Goyal
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124522003151

Similar Items

Hepcidin and HFE Polymorphisms and Ferritin Level in β-Thalassemia Major
by: Kiavash Fekri, et al.
Published: (2019-01-01)

Heterozygous Beta Thalassemia in Parents of Children with Beta Thalassemia Major
by: Imran-ud-Din Khattak, et al.
Published: (2004-06-01)

Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia
by: Murtadha Al-Khabori, et al.
Published: (2013-03-01)

Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study
by: ElMelegy Nagla T, et al.
Published: (2010-05-01)

Relationship between the amount of blood transfusion and the amount of iron chelation with blood and salivary ureum levels in children with beta thalassemia major
by: Pradypta, Putu Gyzca, et al.

Endocrine Complications and the Effect of Compliance with Chelation Therapy in Patients with Beta Thalassemia Major in Eastern Province of Saudi Arabia
by: Habbash F, et al.
Published: (2022-12-01)

Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: Our experience
by: Jethani Jitendra, et al.
Published: (2010-01-01)

Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children
by: Riewpaiboon Arthorn, et al.
Published: (2010-01-01)

Beta Thalassemia Major
by: Muhammad Asghar
Published: (2007-06-01)

Nutritional Status of Children with Beta Thalassemia Major
by: Dhara Bipin Joshi, et al.
Published: (2023-12-01)

Assessment of iron chelation therapy adherence in patients with thalassemia major in Babylon Province
by: Mohammed Ali Al-Jabory, et al.
Published: (2023-01-01)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Ebrahim miri moghaddam, et al.
Published: (2011-04-01)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Mohammad Ali Mashhadi, et al.
Published: (2011-06-01)

Renal Function in Children with β-Thalassemia Major Treated with Iron Chelating Agent
by: Olga Rasiyanti Siregar, et al.
Published: (2020-09-01)

Comparison of the quality of life of patients with a beta-thalassemia major, regularly receiving parenteral and oral chelators
by: Samira Hasanova, et al.
Published: (2022-10-01)

Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients
by: Eziefula C, et al.
Published: (2022-06-01)

Is the Role of Hepcidin and Erythroferrone in the Pathogenesis of Beta Thalassemia the Key to Developing Novel Treatment Strategies?
by: Tsz Yuen Au, et al.
Published: (2022-09-01)

Current and future alternative therapies for beta-thalassemia major
by: Edouard de Dreuzy, et al.
Published: (2016-02-01)

Thyroid functions and levels of some trace elements in children with beta-thalassemia major
by: Mohamed S Zaghlol, et al.
Published: (2019-01-01)

Assessment of serum vitamin D levels in Egyptian children with beta-thalassemia major
by: Ghada Saad Abdelmotaleb, et al.
Published: (2021-09-01)

Osteopenia and Osteoporosis in Children and Adolescents with Beta Thalassemia Major
by: Sumera Akram, et al.
Published: (2023-11-01)

Anthropometry in Children with Transfusion-Dependent Beta-Thalassemia Major
by: Noor Un Nisa, et al.
Published: (2023-12-01)

Determinant factors of depression in beta major thalassemia children
by: AHMAD SURYAWAN, et al.
Published: (2021-04-01)

Dental and oral management in beta major thalassemia in children
by: Eriska Riyanti
Published: (2008-03-01)

EVALUATION OF T LYMPHOCYTE SUBSETS IN CHILDREN WITH BETA THALASSEMIA MAJOR
by: A. Danesh, et al.
Published: (1999-06-01)

EVALUATION OF T LYMPHOCYTE SUBSETS IN CHILDREN WITH BETA THALASSEMIA MAJOR
by: A. Danesh, et al.
Published: (1999-07-01)

A Review of Iron Overload in Beta-Thalassemia Major, and a Discussion on Alternative Potent Iron Chelation Targets
by: Piyush Kumar Yadav, et al.
Published: (2022-05-01)

Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine
by: Mohamed Abdel Malik Hassan, et al.
Published: (2016-05-01)

Melanin nanoparticles as a potential iron chelation therapy for women with beta thalassemia during pregnancy
by: Bakhamis, N
Published: (2022)

Thalassemia Intermedia: Chelator or Not?
by: Yen-Chien Lee, et al.
Published: (2022-09-01)

"Evaluation Of compliance To Iron Chelation Therapy With Defe-Roxamine In Patients With Major Thalassemia In Iran In 2004 "
by: M. Izadyar, et al.
Published: (2006-06-01)

Subclinical renal abnormalities in young thalassemia major and intermedia patients and its relation to chelation therapy
by: Amira A.M. Adly, et al.
Published: (2014-10-01)

A study of thyroid function in children with Beta thalassemia major.
by: Dr. Gargi Pathak, et al.
Published: (2018-06-01)

What regulates hepcidin in poly-transfused β-Thalassemia Major: Erythroid drive or store drive?
by: Richa Chauhan, et al.
Published: (2014-01-01)

Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study
by: Hayder Al-Momen
Published: (2019-04-01)

Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.
by: Jones, E, et al.
Published: (2014)

Dual oral iron chelation in children with transfusion dependent beta thalassemia real world efficacy data
by: Amitoj Singh Chadha, et al.
Published: (2022-01-01)

Clinical Complications of Beta-Thalassemia Major
by: Ali Jalal Shawkat, et al.
Published: (2019-12-01)

Comparative efficacy, safety, and cost of iron chelation monotherapy vs. combination therapy in pediatric beta-thalassemia major: a single-center retrospective study
by: Dewi Sharon Simorangkir, et al.
Published: (2022-03-01)

Combination iron chelation therapy with deferiprone and deferasirox in iron-overloaded patients with transfusiondependent β-thalassemia major
by: Hossein Karami, et al.
Published: (2017-01-01)